Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > 02181 MABPHARM-B > Detailed Quotes

02181 MABPHARM-B

0.355
-0.015-4.05%
Market Close 09/26 16:08 CCT
High
0.360
Open
0.360
Turnover
14.95K
Low
0.355
Pre Close
0.370
Volume
42.00K
Market Cap
1.46B
P/E(TTM)
Loss
52wk High
1.200
Shares
4.12B
P/E(Static)
Loss
52wk Low
0.355
Float Cap
1.46B
Bid/Ask %
28.81%
Historical High
1.800
Shs Float
4.12B
Volume Ratio
0.00
Historical Low
0.355
Dividend TTM
--
Div Yield TTM
--
P/B
2.55
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.00%
Amplitude
1.35%
Avg Price
0.355
Lot Size
2000
Float Cap
1.46B
Bid/Ask %
28.81%
Historical High
1.800
Shs Float
4.12B
Volume Ratio
0.00
Historical Low
0.355
Dividend TTM
--
P/B
2.55
Dividend LFY
--
Turnover Ratio
0.00%
Amplitude
1.35%
Avg Price
0.355
Lot Size
2000
Price Forecast

No Data

News

Comment

Company Overview More
Maibo Pharmaceutical Co., Ltd. is a Chinese company mainly engaged in the research, development and production of monoclonal antibody drugs for cancer and autoimmune diseases. The company's main products include omazumab (CMAB007), cetuximab (CMAB009) and infliximab (CMAB008). The company mainly operates in China.
CEO: Shuge Jiao
Market: Hong Kong motherboard
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...